NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Fred Hutchinson Cancer Center
Conditions: HIV
Interventions: Telehealth delivery of pharmacy PrEP/PEP, Standard pharmacy PrEP/PEP delivery
Countries: Kenya
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
Sex: ALL
Age: 15 Years to —
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Inclusion Criteria: Pharmacies * Registered with the Pharmacy and Poisons Board (PPB) * Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff * Must have a private room where HIV testing and PrEP/PEP counseling can occur * \>3 km from other study pharmacies * Willing to participate in research activities, including 2-day training for pharmacy providers * Willing to share pharmacy records with us * Sells HIVST kits that are WHO certified. Pharmacists/remote nurses * ≥ 18 years old * Licensed pharmacist, pharmaceutical technologist, or nurse * Willing to provide PrEP and PEP services, including HIV testing and associated counseling services * Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing * Able and willing to provide informed consent Clients * ≥ 15 years old * Interested in being screened for PrEP or PEP * Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety * Able and willing to provide informed consent Exclusion Criteria: Clients * Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information * Currently enrolled in any other HIV vaccine or prevention trial * Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives
- Kisumu, Kenya